Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines ; volume:18 ; number:1 ; day:20 ; month:6 ; year:2011 ; pages:1-15 ; date:12.2011
Journal of biomedical science ; 18, Heft 1 (20.6.2011), 1-15, 12.2011
- Creator
-
Wen, Chih-Chun
Chen, Hui-Ming
Chen, Swey-Shen
Huang, Li-Ting
Chang, Wei-Ting
Wei, Wen-Chi
Chou, Li-Chen
Arulselvan, Palanisamy
Wu, Jin-Bin
Kuo, Sheng-Chu
Yang, Ning-Sun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1423-0127-18-44
- URN
-
urn:nbn:de:101:1-2021080706552409208185
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wen, Chih-Chun
- Chen, Hui-Ming
- Chen, Swey-Shen
- Huang, Li-Ting
- Chang, Wei-Ting
- Wei, Wen-Chi
- Chou, Li-Chen
- Arulselvan, Palanisamy
- Wu, Jin-Bin
- Kuo, Sheng-Chu
- Yang, Ning-Sun
- SpringerLink (Online service)
Other Objects (12)
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection